IBEC has co-organized an international workshop in Montpellier, France, to enhance the cooperation of Spanish and French scientists in the research of new applications for the cancer diagnosis and treatment.
The control of stem cell potency is the line of research most recently incorporated into the IBEC program under the leadership of Ángel Raya, a research professor at the Catalan Institute for Research and Advanced Studies (ICREA). This project, which represents an expansion of the institute’s work in the field, now forms part of IBEC’s Cellular Biotechnology research program.
The supply of oxygen and nutrients from capillaries as well as the mechanical stimuli transmitted to cells are critical factors that influence tissue differentiation. The effect of these two factors can be investigated using mechanobiological computational models.The Foreign and Commonwealth Office Science and Innovation Network and the Spanish Technology Platform on Nanomedicine (Nanomed Spain) have organized the UK-Iberia Nanomedicine Workshop. The meeting will be host at the British Embassy in Madrid on Dec 10th and 11th.
The discovery of a new function of the cellular prion protein (PrPc) improves the understanding of epilepsy.
Surprisingly, in both cases, the central nervous excitability threshold is altered to such an extent that an epileptic seizure may result. Thanks to this discovery, we now have more tools at our disposal that can help us to deepen our basic understanding of epilepsy.
The Second China-Europe Symposium on Biomaterials in Regenerative Medicine, hosted by IBEC, takes place in Barcelona from 16 to 20 November.The 2nd China-Europe Symposium on Biomaterials in Regenerative Medicine, which will take place in Barcelona from 16 to 20 November, brings together over 150 participants and the top specialists in biomaterials from these two geographical areas.
In a process essential to the immune system’s response to infection, dendritic cells responsible for identifying pathogens communicate with the T-cells that destroy the infectious agents. To achieve this, the dendritic cells must be correctly activated and migrate to the lymph nodes where they must adhere firmly to T-cells.